Forte Biosciences (FBRX)
(Delayed Data from NSDQ)
$7.58 USD
-0.03 (-0.39%)
Updated Sep 9, 2024 01:50 PM ET
After-Market: $7.34 -0.24 (-3.17%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.58 USD
-0.03 (-0.39%)
Updated Sep 9, 2024 01:50 PM ET
After-Market: $7.34 -0.24 (-3.17%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Zacks News
What Makes Forte Biosciences (FBRX) a New Buy Stock
by Zacks Equity Research
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Biotech Stock Roundup: MRNA Submits Vaccine Data, BMRN Down on Clinical Hold & More
by Zacks Equity Research
Regulatory and pipeline updates from Moderna (MRNA) and BioMarin (BMRN), among others, have been in focus in the biotech industry over the past week.
Forte (FBRX) Posts Dismal Data on Atopic Dermatitis Candidate
by Zacks Equity Research
Forte's (FBRX) mid-stage study on its lead candidate FB-401 to address the condition of atopic dermatitis fails to meet its primary goal and the company decides to discontinue the study further.
Implied Volatility Surging for Forte Biosciences (FBRX) Stock Options
by Aditi Saraogi
Investors need to pay close attention to for Forte Biosciences (FBRX) stock based on the movements in the options market lately.